��������Ƶ

Andrew Vallely is Head of the Asia and Pacific Health Program at the Kirby Institute for Infection and Immunity in Society, Faculty of Medicine, UNSW Sydney. He is a medically-trained clinical epidemiologist with more than 30 years’ experience living and working in low- and middle-income countries (LMIC) in sub-Saharan Africa, Asia and the Pacific. In 2007, he jointly established an international collaborative research group in sexual and reproductive health at the Papua New Guinea Institute of Medical Research (PNGIMR) in Goroka, where he was Deputy Director from 2010-2015. At the PNGIMR, he led the first field trials in any setting of point-of-care human papillomavirus (HPV) self-collection, testing and treatment for cervical screening (the HPV-STAT trial); and the first trial of antenatal point-of-care testing and treatment of sexually transmitted infections (STI) to improve birth outcomes (the WANTAIM trial). With colleagues at the Daffodil Centre (a joint venture between University of Sydney and Cancer Council New South Wales), the Australian Centre for the Prevention of Cervical Cancer (ACPCC), Family Planning Australia (FPA), and in-country partners, Andrew jointly leads the Eliminate Cervical Cancer across the Western Pacific (ECCWP) program, a world-first initiative that brings together landmark philanthropic, industry, government, and development partner investments to advance elimination in Papua New Guinea, Vanuatu, and the region.